EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Landscape of Cancer Metabolism as a Therapeutic Target

Kenji Ohshima iD

Pathology International · 2025

DOI: 10.1111/pin.70034 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology International, 2025. Verfasst von Kenji Ohshima. Beteiligte Einrichtung: Department of Molecular Pathology, Faculty of Medicine, Hyogo Medical University, Nishinomiya, Japan. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells reprogram their metabolism during progression to adapt to the tumor microenvironment, which is characterized by distinct differences in nutrient availability, oxygen concentrations, and acidity. This metabolic reprogramming can simultaneously create metabolic vulnerabilities unique to cancer cells, making cancer metabolism a promising therapeutic target. Since the clinical application of folate antimetabolites in the 1940s, numerous therapeutic strategies targeting cancer metabolism have been developed. In recent years, advancements in technologies such as metabolome analysis have facilitated the development of agents that more specifically target cancer cell metabolism. However, these newly developed agents often face challenges in demonstrating efficacy as monotherapies in clinical trials. Nevertheless, combination therapies, designed based on precise mechanistic insights and incorporating agents such as immune‐checkpoint and signaling‐pathway inhibitors, have shown promising efficacy. This review provides an overview of the current landscape of therapeutic strategies targeting cancer metabolism, with a particular focus on approaches targeting amino acid, fatty acid, and glucose metabolism in cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansTumor MicroenvironmentAnimalsMolecular Targeted TherapyFatty Acids

Stichwörter der Autor:innen

amino acid metabolismcancer metabolismcancer therapycombination therapyfatty acid metabolismglucose metabolism

Substanzen

Antineoplastic AgentsFatty Acids

Autor:innen und Institutionen

  • Department of Molecular Pathology, Faculty of Medicine, Hyogo Medical University, Nishinomiya, Japan.

ORCID-Profile: Kenji Ohshima

Zitieren

APA

Ohshima, K. (2025). The Landscape of Cancer Metabolism as a Therapeutic Target. Pathology International. https://doi.org/10.1111/pin.70034

Vancouver

Ohshima K. The Landscape of Cancer Metabolism as a Therapeutic Target. Pathology International. 2025. doi:10.1111/pin.70034

BibTeX
@article{Ohshima2025,
  author = {Ohshima, Kenji},
  title = {The Landscape of Cancer Metabolism as a Therapeutic Target},
  journal = {Pathology International},
  year = {2025},
  doi = {10.1111/pin.70034}
}
Kostenlos starten →